Drug Shortage Report for TEVA-SILDENAFIL R
| Report ID | 120259 |
| Drug Identification Number | 02319500 |
| Brand name | TEVA-SILDENAFIL R |
| Common or Proper name | SILDENAFIL R 20MG COATED TAB |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | SILDENAFIL |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | C02KX |
| ATC description | OTHER ANTIHYPERTENSIVES |
| Reason for shortage | Shortage of an inactive ingredient or component. |
| Anticipated start date | |
| Actual start date | 2020-07-14 |
| Estimated end date | 2020-12-31 |
| Actual end date | 2020-07-14 |
| Shortage status | Resolved |
| Updated date | 2020-07-15 |
| Company comments | duplicate record created in error - end dated to remove |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2020-07-15 | English | Compare |
| v4 | 2020-07-14 | French | Compare |
| v3 | 2020-07-14 | English | Compare |
| v2 | 2020-07-14 | French | Compare |
| v1 | 2020-07-14 | English | Compare |
Showing 1 to 5 of 5